IL140918A0 - Improved transformation efficiency in phage display through modification of a coat protein - Google Patents

Improved transformation efficiency in phage display through modification of a coat protein

Info

Publication number
IL140918A0
IL140918A0 IL14091899A IL14091899A IL140918A0 IL 140918 A0 IL140918 A0 IL 140918A0 IL 14091899 A IL14091899 A IL 14091899A IL 14091899 A IL14091899 A IL 14091899A IL 140918 A0 IL140918 A0 IL 140918A0
Authority
IL
Israel
Prior art keywords
modification
phage display
transformation efficiency
coat protein
improved transformation
Prior art date
Application number
IL14091899A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL140918A0 publication Critical patent/IL140918A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14091899A 1998-07-27 1999-07-22 Improved transformation efficiency in phage display through modification of a coat protein IL140918A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9429198P 1998-07-27 1998-07-27
US10351498P 1998-10-08 1998-10-08
US13329699P 1999-05-10 1999-05-10
US13487099P 1999-05-19 1999-05-19
PCT/US1999/016596 WO2000006717A2 (en) 1998-07-27 1999-07-22 Improved transformation efficiency in phage display through modification of a coat protein

Publications (1)

Publication Number Publication Date
IL140918A0 true IL140918A0 (en) 2002-02-10

Family

ID=27492720

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14091899A IL140918A0 (en) 1998-07-27 1999-07-22 Improved transformation efficiency in phage display through modification of a coat protein

Country Status (7)

Country Link
US (1) US8685893B2 (ja)
EP (1) EP1100890A2 (ja)
JP (1) JP2002522029A (ja)
AU (1) AU5122499A (ja)
CA (1) CA2334170A1 (ja)
IL (1) IL140918A0 (ja)
WO (1) WO2000006717A2 (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100890A2 (en) 1998-07-27 2001-05-23 Genentech, Inc. Improved transformation efficiency in phage display through modification of a coat protein
JP2004512010A (ja) * 2000-03-29 2004-04-22 ディージーアイ・バイオテクノロジーズ・エル・エル・シー インスリン及びｉｇｆ−１受容体のアゴニスト及びアンタゴニスト
DE10129815A1 (de) * 2001-06-24 2003-01-09 Profos Ag Verfahren zur Aufreinigung von Bakterienzellen und Zellbestandteilen
US7112435B1 (en) * 2002-08-07 2006-09-26 Ambit Biosciences Corporation Uncoupling of DNA insert propagation and expression of protein for phage display
EP2305710A3 (en) 2002-06-03 2013-05-29 Genentech, Inc. Synthetic antibody phage libraries
KR20050044886A (ko) 2002-07-05 2005-05-13 데니스 르클레르 면역보조 바이러스 입자
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
US7897381B2 (en) * 2002-08-07 2011-03-01 Ambit Biosciences Corporation Uncoupling of DNA insert propagation and expression of protein for phage display
US7833741B2 (en) 2002-08-07 2010-11-16 Ambit Biosciences Corporation Uncoupling of DNA insert propagation and expression of protein for phage display
US20060122377A1 (en) 2004-02-19 2006-06-08 Genentech, Inc. CDR-repaired antibodies
EP2465870A1 (en) 2005-11-07 2012-06-20 Genentech, Inc. Binding polypeptides with diversified and consensus VH/VL hypervariable sequences
ES2385261T3 (es) 2006-04-10 2012-07-20 Genentech, Inc. Moduladores de PDZ Disheveled
MX366269B (es) 2011-09-30 2019-07-04 Chugai Pharmaceutical Co Ltd Biblioteca de moleculas de union dependientes de la concentracion ionica.
CA2851371A1 (en) 2011-10-14 2013-04-18 Genentech, Inc. Zymogen activators
CN103974709B (zh) 2011-10-14 2016-12-14 霍夫曼-拉罗奇有限公司 Bace1的肽抑制剂
CN104254541A (zh) 2012-03-16 2014-12-31 弗·哈夫曼-拉罗切有限公司 改造的构象稳定蛋白质
US9139863B2 (en) 2012-03-16 2015-09-22 Genentech, Inc. Engineered conformationally-stabilized proteins
TWI652279B (zh) 2013-11-11 2019-03-01 中外製藥股份有限公司 含改變的抗體可變區之抗原結合分子
US11473080B2 (en) 2014-04-30 2022-10-18 The Board Of Trustees Of The University Of Illinois Method for generating high affinity, bivalent binding agents for sandwich assays
US11034992B2 (en) 2016-03-23 2021-06-15 The General Hospital Corporation Assays and methods for detecting UDP-glucose
CA3046561A1 (en) 2016-12-12 2018-06-21 Hurrah S.A R.L. Compositions and methods for increasing the immunoglobulin binding capacities of immunoglobulin-binding polypeptides and oligopeptides
CN111601897A (zh) 2016-12-30 2020-08-28 奎多公司 用于确定细菌对抗生素或益菌剂的易感性的噬菌体介导的免疫分析和方法
CN111788314A (zh) 2017-10-02 2020-10-16 奎多公司 用于抗微生物剂敏感性测试和细菌菌种确认的基于噬菌体的检测方法
US11492645B2 (en) 2018-08-29 2022-11-08 Shanghaitech University Composition and use of Cas protein inhibitors
US11454347B2 (en) 2020-04-01 2022-09-27 Texas Smart Solutions, LLC Collapsible stand and cover
CN116249774A (zh) 2020-05-26 2023-06-09 迪奥尼斯治疗公司 核酸人工微型蛋白质组文库
WO2022167396A1 (en) 2021-02-02 2022-08-11 Biocopy Gmbh Method for identifying emerging pathogen mutations enabling host cell entry and immune evasion
WO2023076733A1 (en) 2021-11-01 2023-05-04 Dana-Farber Cancer Institute, Inc. Biologically selected nucleic acid artificial mini-proteome libraries

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3546806C2 (ja) 1985-03-30 1991-03-28 Marc Genf/Geneve Ch Ballivet
US6492107B1 (en) 1986-11-20 2002-12-10 Stuart Kauffman Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
US4848355A (en) 1985-05-20 1989-07-18 Matsushita Electric Industrial Co., Ltd. Ultrasonic doppler blood flowmeter
US4822740A (en) 1985-10-07 1989-04-18 Microlife Technics, Inc. Bacteria for expressing a polysaccharide depolymerase containing a novel recombinant plasmid
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US5139935A (en) 1987-02-19 1992-08-18 Mitsui Toatsu Chemicals, Incorporated Method of regulating expression of a foreign gene by controlling the sugar concentration in a medium and a process of producing a foreign product thereby
US5098843A (en) 1987-06-04 1992-03-24 Calvin Noel M Apparatus for the high efficiency transformation of living cells
US5128257A (en) 1987-08-31 1992-07-07 Baer Bradford W Electroporation apparatus and process
US4910140A (en) 1988-04-18 1990-03-20 Bio-Rad Laboratories, Inc. Electroporation of prokaryotic cells
US5186800A (en) 1988-04-18 1993-02-16 Bio-Rad Laboratories, Inc. Electroporation of prokaryotic cells
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5266684A (en) 1988-05-02 1993-11-30 The Reagents Of The University Of California Peptide mixtures
US5571689A (en) 1988-06-16 1996-11-05 Washington University Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid
US5663143A (en) 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5750373A (en) 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
ATE189526T1 (de) 1988-10-28 2000-02-15 Genentech Inc Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
US6780613B1 (en) 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
US5124259A (en) 1989-08-23 1992-06-23 Mitsui Toatsu Chemicals, Inc. Method for electroporation
ATE201047T1 (de) 1990-01-08 2001-05-15 Stratagene Inc Neue wirtsorganismen zur klonierung
US5498538A (en) 1990-02-15 1996-03-12 The University Of North Carolina At Chapel Hill Totally synthetic affinity reagents
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
CA2019758C (en) 1990-06-25 2001-09-04 Kevin L. Firth Improved electroporation device and method
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
IL99553A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing oligonucleotides linked to expression elements,a kit for the preparation of vectors useful for the expression of a diverse population of random peptides and methods utilizing the same
US5770434A (en) 1990-09-28 1998-06-23 Ixsys Incorporated Soluble peptides having constrained, secondary conformation in solution and method of making same
US5780279A (en) 1990-12-03 1998-07-14 Genentech, Inc. Method of selection of proteolytic cleavage sites by directed evolution and phagemid display
GB9101550D0 (en) 1991-01-24 1991-03-06 Mastico Robert A Antigen-presenting chimaeric protein
JP3547129B2 (ja) 1991-02-19 2004-07-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 変更宿主域を有するウィルス粒子
DK1471142T3 (da) 1991-04-10 2009-03-09 Scripps Research Inst Heterodimere receptor-biblioteker under anvendelse af fagemider
US5858657A (en) 1992-05-15 1999-01-12 Medical Research Council Methods for producing members of specific binding pairs
US5173158A (en) 1991-07-22 1992-12-22 Schmukler Robert E Apparatus and methods for electroporation and electrofusion
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5667988A (en) 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
DK0663953T3 (da) 1992-09-04 2002-04-02 Scripps Research Inst Phagimider, som co-udtrykker en overfladereceptor og et overfladeheterologt protein
US5723287A (en) 1992-09-22 1998-03-03 Medical Research Council Recombinant viruses displaying a nonviral polypeptide on their external surface
WO1994011496A1 (en) * 1992-11-10 1994-05-26 Ixsys, Inc. Soluble peptides having constrained, secondary conformation in solution and method of making same
DE614989T1 (de) 1993-02-17 1995-09-28 Morphosys Proteinoptimierung Verfahren für in vivo Selektion von Ligandenbindende Proteine.
US5422272A (en) 1993-07-14 1995-06-06 Andrew A. Papp Improvements to apparatus and method for electroporation
US5512468A (en) 1993-11-12 1996-04-30 Stratagene Process of producing highly transformable bacterial cells and cells produced thereby
SE9304060D0 (sv) 1993-12-06 1993-12-06 Bioinvent Int Ab Sätt att selektera specifika bakteriofager
JP3531880B2 (ja) 1994-02-28 2004-05-31 社団法人北里研究所 新規ネコ免疫不全ウイルス株及びその外被膜蛋白質遺伝子ｒｎａに対応するｄｎａ並びにネコ免疫不全ウイルスワクチン
JPH10507341A (ja) 1994-03-30 1998-07-21 アイジェン， インコーポレイテッド ファージ技術を用いる触媒性抗体の単離および産生
AU7104294A (en) 1994-06-10 1996-01-05 Symbiotech, Inc. Method of detecting compounds utilizing genetically modified lambdoid bacteriophage
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
US5627024A (en) 1994-08-05 1997-05-06 The Scripps Research Institute Lambdoid bacteriophage vectors for expression and display of foreign proteins
GB9500851D0 (en) 1995-01-17 1995-03-08 Bionvent International Ab Method of selecting specific bacteriophages
US5702892A (en) 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
WO1997002342A1 (en) 1995-06-30 1997-01-23 Københavns Universitet Recombinant antibodies from a phage display library, directed against a peptide-mhc complex
AUPN523995A0 (en) 1995-09-05 1995-09-28 Crc For Biopharmaceutical Research Pty Ltd Method for producing phage display vectors
GB2304718B (en) 1995-09-05 2000-01-19 Degussa The production of tryptophan by the bacterium escherichia coli
ATE239799T1 (de) 1995-09-07 2003-05-15 Novozymes As Nachweis der aktivität von enzymen für detergenzien durch phagen.
US5622699A (en) 1995-09-11 1997-04-22 La Jolla Cancer Research Foundation Method of identifying molecules that home to a selected organ in vivo
JPH11513249A (ja) 1995-09-27 1999-11-16 メディカル・リサーチ・カウンシル プロテアーゼにより開裂可能なタンパク質を組込んだ組換えウイルス
SE506771C2 (sv) 1996-02-06 1998-02-09 Gotpat 105 Ab Fusionsprotein, bakteriofag uttryckande proteinet, dessas användning samt hybridoma celler och monoklonaler producerade av cellerna
US6084062A (en) 1996-03-20 2000-07-04 Dyax Corp. Polypeptides that bind to tissue plasminogen activator (tPA)
GB9608540D0 (en) 1996-04-25 1996-07-03 Medical Res Council Isolation of enzymes
AU3135097A (en) 1996-05-22 1997-12-09 Johns Hopkins University, The Methods of detection utilizing modified bacteriophage
CA2256449A1 (en) 1996-06-06 1997-12-11 Lajolla Pharmaceutical Company Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
EP0959894B1 (en) 1996-06-10 2004-10-13 The Scripps Research Institute Use of substrate subtraction libraries to distinguish enzyme specificities
US5766905A (en) 1996-06-14 1998-06-16 Associated Universities Inc. Cytoplasmic bacteriophage display system
US6911526B2 (en) 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
WO1998005344A1 (en) 1996-08-05 1998-02-12 Brigham And Women's Hospital, Inc. Bacteriophage-mediated gene therapy
WO1998014277A1 (en) 1996-10-04 1998-04-09 Whatman, Inc. Device and method for simultaneous multiple chemical syntheses
DK0934526T3 (da) 1996-10-08 2003-05-05 Bisys B V U Fremgangsmåder og midler til udvælgelse af peptider og proteiner, der har specifik affinitet til et mål
WO1998020036A1 (en) 1996-11-06 1998-05-14 Genentech, Inc. Constrained helical peptides and methods of making same
IL119587A (en) 1996-11-07 2000-12-06 Univ Ramot Method of preparing and for obtaining bimolecular interactions
IL119586A (en) 1996-11-07 2001-09-13 Univ Ramot Discontinuous library of a single biological unit and a method for its preparation
IT1291913B1 (it) 1997-05-22 1999-01-21 Angeletti P Ist Richerche Bio Metodo che prevede l'uso di batteriofagi per la rivelazione della presenza di molecole di interesse in campioni biologici
US6054312A (en) 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
US6794128B2 (en) 1998-04-24 2004-09-21 The Regents Of The University Of California Methods of selecting internalizing antibodies
CA2328422A1 (en) 1998-05-13 1999-11-18 Diversys Limited Selection system
EP1100890A2 (en) 1998-07-27 2001-05-23 Genentech, Inc. Improved transformation efficiency in phage display through modification of a coat protein
US6190908B1 (en) 1998-08-12 2001-02-20 The Scripps Research Institute Modulation of polypeptide display on modified filamentous phage
EP1178817A2 (en) 1999-05-14 2002-02-13 Arbor Vita Corporation Molecular interactions in haematopoietic cells
US20050019841A1 (en) 1999-05-14 2005-01-27 Arbor Vita Corporation Modulation of signaling pathways
EP1212682B8 (en) 1999-07-14 2016-12-28 Symantec Corporation System and method for quickly authenticating messages using sequence numbers
AU1499601A (en) 1999-11-25 2001-06-04 Basf Plant Science Gmbh Moss genes from physcomitrella patents encoding proteins involved in the synthesis of polyunsaturated fatty acids and lipids
WO2001079559A1 (en) 2000-04-18 2001-10-25 Wayne State University System to detect protein-protein interactions
US20030148264A1 (en) 2001-07-06 2003-08-07 Genentech, Inc. Phage displayed PDZ domain ligands

Also Published As

Publication number Publication date
WO2000006717A9 (en) 2000-11-16
CA2334170A1 (en) 2000-02-10
EP1100890A2 (en) 2001-05-23
US8685893B2 (en) 2014-04-01
AU5122499A (en) 2000-02-21
WO2000006717A2 (en) 2000-02-10
JP2002522029A (ja) 2002-07-23
US20120165226A1 (en) 2012-06-28
WO2000006717A3 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
IL140918A0 (en) Improved transformation efficiency in phage display through modification of a coat protein
EP1064022A4 (en) HLA BINDING PEPTIDES AND THEIR APPLICATIONS
EP1043550A4 (en) REFRIGERATION CIRCUIT
IL135170A0 (en) Heat-insulating coating
HUP0002789A3 (en) Integrin binding peptide and use thereof
GB2329003B (en) Magnetic valve
GB9706816D0 (en) Consumer model
GB9806806D0 (en) Peptides and uses thereof
IS4561A (is) Efnablöndur sem innihalda asaþíóprín með verkun íristli
EP1018308A4 (en) BLOCK LINK STRUCTURE AND STRIP-SHAPED ORNAMENT
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
GB0029361D0 (en) Combinatorial molecule design system and method
EP1073458A4 (en) CHLAMYDIA PROTEINS AND ITS USE
GB9703016D0 (en) Animation system and mehod
GB9918155D0 (en) Proteins and peptides
IL147345A0 (en) Drosphila recombination- associated protein and methods for use
IL145711A0 (en) Thrombospondin-2 and uses thereof
GB9722901D0 (en) Improvements in coatings
SG64479A1 (en) Reactive dyes their preparation and use
GB9727307D0 (en) Pipeline
GB9807890D0 (en) Peptides
EP1132472A4 (en) NEW PROTEIN AND ITS APPLICATION
IL146940A0 (en) Novel calpains and their use
GB9723062D0 (en) Improvements relating to antibodies and libraries thereof
GB9720633D0 (en) BHV-2 vector